BetterScholar BetterScholar
11
Role
Title
Level Year L/R
🐜 Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis
80 auth. Alessandro Cassini, L. Högberg, D. Plachouras, A. Quattrocchi, Ana Hoxha, G. S. Simonsen, M. Colomb-Cotinat, M. Kretzschmar, B. Devleesschauwer, M. Cecchini, D. A. Ouakrim, T. C. Oliveira, M. Struelens, C. Suetens, D. Monnet, ... R. Strauss, K. Mertens, T. Struyf, B. Catry, K. Latour, I. Ivanov, E. Dobreva, A. Tambić Andrašević, S. Šoprek, A. Budimir, N. Paphitou, H. Žemličková, Stefan Schytte Olsen, Ute Wolff Sönksen, Pille Märtin, M. Ivanova, O. Lyytikäinen, J. Jalava, B. Coignard, T. Eckmanns, Muna Abu Sin, S. Haller, G. Daikos, A. Gikas, S. Tsiodras, F. Kontopidou, Á. Tóth, Á. Hajdú, Ólafur Guólaugsson, K. Kristinsson, S. Murchan, K. Burns, P. Pezzotti, C. Gagliotti, U. Dumpis, Agne Liuimiene, M. Perrin, M. Borg, S. D. de Greeff, J. Monen, M. Koek, P. Elstrøm, D. Żabicka, A. Deptuła, W. Hryniewicz, M. Caniça, P. Nogueira, Paulo André Fernandes, Vera Manageiro, G. Popescu, R. Șerban, Eva Schréterová, S. Litvová, M. Štefkovičová, J. Kolman, I. Klavs, A. Korošec, B. Aracil, Á. Asensio, M. Pérez-Vázquez, H. Billström, S. Larsson, J. Reilly, Alan P. Johnson, S. Hopkins
10 2019
10
🐜
🦁 Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.
14 auth. C. Gagliotti, A. Balode, Fernando Baquero, John E. Degener, Hajo Grundmann, Deniz Gür, Vincent Jarlier, Gunnar Kahlmeter, J. Monen, D L Monnet, ... G. M. Rossolini, Carl Suetens, K. Weist, O. Heuer
7 2011
7
🦁
🐜 Chikungunya virus in North-Eastern Italy: a seroprevalence survey.
14 auth. M. Moro, C. Gagliotti, G. Silvi, R. Angelini, V. Sambri, G. Rezza, E. Massimiliani, A. Mattivi, E. Grilli, A. Finarelli, ... Nadir Spataro, A. Pierro, T. Seyler, P. Macini
7 2010
7
🐜
🐜 Long-term chikungunya infection clinical manifestations after an outbreak in Italy: a prognostic cohort study.
15 auth. M. Moro, E. Grilli, A. Corvetta, G. Silvi, R. Angelini, F. Mascella, F. Miserocchi, P. Sambo, A. Finarelli, V. Sambri, ... C. Gagliotti, E. Massimiliani, A. Mattivi, A. Pierro, P. Macini
6 2012
6
🐜
🐬 The rise of carbapenem resistance in Europe: just the tip of the iceberg?
A. Magiorakos, C. Suetens, D. Monnet, C. Gagliotti, O. Heuer
6 2013
6
🐬
🐜 Prenatal education for congenital toxoplasmosis.
7 auth. S. Di Mario, V. Basevi, C. Gagliotti, D. Spettoli, G. Gori, R. D'amico, ... N. Magrini
6 2015
6
🐜
🐜 Feasibility and effectiveness of a low cost campaign on antibiotic prescribing in Italy: community level, controlled, non-randomised trial
8 auth. G. Formoso, B. Paltrinieri, A. Marata, C. Gagliotti, A. Pan, M. Moro, ... O. Capelli, N. Magrini
6 2013
6
🐜
🐜 The Italian national surgical site infection surveillance programme and its positive impact, 2009 to 2011.
7 auth. M. Marchi, A. Pan, C. Gagliotti, F. Morsillo, M. Parenti, D. Resi, ... M. L. Moro
6 2014
6
🐜
🦁 Delay in the treatment of pulmonary TB in a changing demographic scenario.
C. Gagliotti, D. Resi, M. Moro
6 2006
6
🦁
🐜 Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017
9 auth. Simone Iacchini, M. Sabbatucci, C. Gagliotti, G. Rossolini, M. Moro, S. Iannazzo, ... F. D'Ancona, P. Pezzotti, A. Pantosti
5 2019
5
🐜
🐜 Outbreak of Citrobacter freundii carrying VIM-1 in an Italian Hospital, identified during the carbapenemases screening actions, June 2012.
15 auth. P. Gaibani, S. Ambretti, P. Farruggia, G. Bua, A. Berlingeri, M. V. Tamburini, M. Cordovana, L. Guerra, M. Mazzetti, G. Roncarati, ... Ciro Tenace, M. Moro, C. Gagliotti, M. Landini, V. Sambri
5 2013
5
🐜